Similarly, LPL enhancement, corresponding to a 1-SD reduction in TG, was significantly causally associated with a lower risk of migraine (FinnGen dataset: OR = 0.82, [95% CI, 0.69–0.96], p = 0.01; Choquet dataset: OR = 0.91, [95% CI, 0.83–0.99], p = 0.03; pooled estimates: OR = 0.89, [95% CI, 0.83–0.96], p = 0.002). Here, LPL is linked to migraine disorder.